(Q48456153)

English

The effect of 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one (ODQ) and charybdotoxin (CTX) on relaxations of isolated cerebral arteries to nitric oxide.

scientific article published in February 1998

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/9526059

The effect of 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one (ODQ) and charybdotoxin (CTX) on relaxations of isolated cerebral arteries to nitric oxide. (English)

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/9526059

author name string

Onoue H

1

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/9526059

Katusic ZS

2

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/9526059

language of work or name

0 references

publication date

1 February 1998

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/9526059

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/9526059

785

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/9526059

1

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/9526059

107-113

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/9526059

Nitric oxide and cGMP cause vasorelaxation by activation of a charybdotoxin-sensitive K channel by cGMP-dependent protein kinase

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901393-0

7 January 2021

Nitric oxide directly activates calcium-dependent potassium channels in vascular smooth muscle.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901393-0

7 January 2021

Nitric oxide: a physiologic messenger molecule

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901393-0

7 January 2021

Zaprinast increases cyclic GMP levels in plasma and in aortic tissue of rats

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901393-0

7 January 2021

Nitric oxide and the cerebral circulation

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901393-0

7 January 2021

The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901393-0

7 January 2021

Purification, sequence, and model structure of charybdotoxin, a potent selective inhibitor of calcium-activated potassium channels

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901393-0

7 January 2021

Bright and dark sides of nitric oxide in ischemic brain injury

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901393-0

7 January 2021

The pharmacological and physiological role of cyclic GMP in vascular smooth muscle relaxation

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901393-0

7 January 2021

Vasopressin causes endothelium-dependent relaxations of the canine basilar artery

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901393-0

7 January 2021

Experimental pneumococcal meningitis: cerebrovascular alterations, brain edema, and meningeal inflammation are linked to the production of nitric oxide

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901393-0

7 January 2021

Nitric oxide measured by a porphyrinic microsensor in rat brain after transient middle cerebral artery occlusion

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901393-0

7 January 2021

Complexes of .NO with nucleophiles as agents for the controlled biological release of nitric oxide. Vasorelaxant effects

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901393-0

7 January 2021

Charybdotoxin, a protein inhibitor of single Ca2+-activated K+ channels from mammalian skeletal muscle

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901393-0

7 January 2021

L-arginine infusion promotes nitric oxide-dependent vasodilation, increases regional cerebral blood flow, and reduces infarction volume in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901393-0

7 January 2021

cGMP mediates the vascular and platelet actions of nitric oxide: confirmation using an inhibitor of the soluble guanylyl cyclase.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901393-0

7 January 2021

Relaxant effects of forskolin in smooth muscle. Role of cyclic AMP.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901393-0

7 January 2021

Physiological roles and properties of potassium channels in arterial smooth muscle

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901393-0

7 January 2021

Role of potassium channels in relaxations of canine middle cerebral arteries induced by nitric oxide donors

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901393-0

7 January 2021

Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901393-0

7 January 2021

cGMP-dependent protein kinase activates Ca-activated K channels in cerebral artery smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901393-0

7 January 2021

Effects of a novel inhibitor of guanylyl cyclase on dilator responses of mouse cerebral arterioles.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901393-0

7 January 2021

Redox signaling: nitrosylation and related target interactions of nitric oxide

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901393-0

7 January 2021

Cyclic GMP phosphodiesterase inhibitors. 1. The discovery of a novel potent inhibitor, 4-((3,4-(methylenedioxy)benzyl)amino)-6,7,8-trimethoxyquinazoline

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901393-0

7 January 2021

Endotoxin decreases the contractile responses of the porcine basilar artery to vasoactive substances.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901393-0

7 January 2021

Guanosine 5'-monophosphate modulates gating of high-conductance Ca2+-activated K+ channels in vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901393-0

7 January 2021

Nitric oxide donors increase blood flow and reduce brain damage in focal ischemia: evidence that nitric oxide is beneficial in the early stages of cerebral ischemia

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901393-0

7 January 2021

Identifiers

10.1016/S0006-8993(97)01393-0

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/9526059

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/9526059

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48456153&oldid=1372559072"